EXICURE, INC.

Profile

Company Names

EXICURE, INC.
AURASENSE THERAPEUTICS, LLC

Addresses

8045 LAMON AVENUE, SUITE 410, SKOKIE, IL 60077

1801 MAPLE AVENUE, SUITE 4301, EVANSTON, IL 60201

Phone Numbers

8476731700
847-673-1700
8474672874

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2011

State Incorporated:

DELAWARE

Total Amount Raised:

$33,630,000.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2015-10-13 
$14,798,400.00 
INDEFINITE 
INDEFINITE 
Equity 
2
2014-06-13 
$13,400,000.00 
INDEFINITE 
INDEFINITE 
Equity 
1
2011-12-16 
$5,431,600.00 
INDEFINITE 
INDEFINITE 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID 
A. 
GILJOHANN 
EXECUTIVE OFFICER, DIRECTOR
AURASENSE THERAPEUTICS, LLC   |  EXICURE, INC.   |  EXICURE, INC.
HELEN 
S. 
KIM 
DIRECTOR
EXICURE, INC.   |  EXICURE, INC.   |  A2 BIOTHERAPEUTICS, INC.   |  ICONOVIR BIO, INC.   |  RECODE THERAPEUTICS, INC.   |  AKTIS ONCOLOGY, INC.
CHAD 
A. 
MIRKIN 
EXECUTIVE OFFICER, DIRECTOR
AURASENSE THERAPEUTICS, LLC   |  EXICURE, INC.   |  CDJ TECHNOLOGIES, INC.   |  MATTIQ, INC.
DAVID 
S. 
SNYDER 
EXECUTIVE OFFICER
CELLULAR DYNAMICS INTERNATIONAL, INC.   |  EXICURE, INC.   |  EXICURE, INC.
C. 
SHAD 
THAXTON 
EXECUTIVE OFFICER, DIRECTOR
AURASENSE THERAPEUTICS, LLC   |  EXICURE, INC.   |  EXICURE, INC.
PERCY 
 
VAN CROCKER, JR. 
EXECUTIVE OFFICER
AURASENSE THERAPEUTICS, LLC
JAY 
 
VENKATESAN 
DIRECTOR
LION BIOTECHNOLOGIES, INC.   |  AURASENSE THERAPEUTICS, LLC   |  ONCOTHYREON INC.   |  ALPINE IMMUNE SCIENCES, INC.   |  TRANSPLANT GENOMICS INC.   |  ANGION BIOMEDICA CORP.   |  TIVORSAN PHARMACEUTICALS, INC.   |  ALPINE IMMUNE SCIENCES, INC.   |  ELICIO THERAPEUTICS, INC.
JAY 
R. 
VENKATESAN 
DIRECTOR
EXICURE, INC.   |  EXICURE, INC.   |  ANGION BIOMEDICA CORP.
DAVID 
 
WALT 
DIRECTOR
QUANTERIX CORP   |  AURASENSE THERAPEUTICS, LLC   |  SHERLOCK BIOSCIENCES, INC.   |  VIZGEN, INC.   |  ARBOR BIOTECHNOLOGIES, INC.   |  PROTILLION BIOSCIENCES, LNC.   |  EVEREST BIOLABS, INC.
DAVID 
R. 
WALT 
DIRECTOR
ULTIVUE, INC.   |  EXICURE, INC.   |  CERULEAN PHARMA INC.   |  ARBOR BIOTECHNOLOGIES, INC.   |  EXICURE, INC.   |  QUANTERIX CORP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-10-23
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-10-13 
2014-06-26
D
Link
BIOTECHNOLOGY 
 
$5,000,001 - $25,000,000 
Equity 
2014-06-13 
2012-01-17
D
Link
BIOTECHNOLOGY 
 
$5,000,001 - $25,000,000 
Equity 
2011-12-16 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#